Calendar

Oracle combines positive three-month EPS and revenue estimate revisions with a sharp pre-event rebound and an AI/cloud backlog catalyst, but the latest verified closes did not meet the required 0.75 close-location threshold and negative fiscal-year free cash flow keeps risk hygiene below full marks.

Adobe has credible AI-driven business momentum and a strong prior quarter, but the stock entered the event in a sharp decline, with no verified positive estimate revision or revenue upside signal and no required close-location confirmation.

Copart has a verified close-location pass and a prior operationally strong quarter, but consensus EPS and revenue revisions were flat-to-negative and the latest five-session tape was weak, so the evidence does not support an upside-surprise setup.

Forgent has unusually strong backlog, bookings, guidance, and recent price momentum, but the latest EPS consensus was revised down over three months and verified volume was only about 1.49 times its 10-day average, leaving this as a speculative partial setup rather than a clean surprise screen hit.

General Mills is disqualified because the supplied September 15 date conflicts with checked market-calendar sources showing September 23, while the verified tape was weak and company guidance called for flat-to-negative organic sales and lower adjusted operating profit.

The primary Q2 release is confirmed and the initial market reaction was positive, with the stock closing at $1.07, up 4.9% on September 8. News tone is constructive on growth and the dividend, but the reaction was modest relative to the revenue increase, while analyst revisions, consensus surprise data, options positioning, short interest, and social coverage are unavailable. Zero sentiment fields represent missing data, not neutral readings.

Initial headline tone is constructive following the earnings release, centered on record free cash flow, adjusted EBITDA growth, and fiscal 2027 guidance. Secondary coverage suggests a positive immediate reaction, but the magnitude and attribution are not independently confirmed. Analyst revision data and social sentiment coverage are unavailable, so this remains a cautious monitoring thesis.

The T+1 post-earnings view is mixed-to-negative: adjusted EPS increased and debt declined, but sales fell year over year, Lilly Pulitzer remained weak, and fiscal 2026 guidance was lowered [#SEC-8K-2026-09-03]. No verified analyst target revisions or consensus-surprise dataset is available in the packet, and social coverage is absent. Given the high thesis-change score, low coverage and limited forward visibility, this remains a cautious monitoring view.

Primary-source tone is constructive after the Q3 release, with raised guidance, strong cash flow, and record revenue. Pre-print consensus was $1.01 EPS and $2.3 billion revenue, while reported adjusted EPS was $1.04 and revenue was approximately $2.3 billion. [#PR-EARNINGS-2026-09-02] Early secondary coverage described a cautious premarket reaction despite the solid print; post-print target changes, estimate revisions, and a verified closing move remain unavailable. The setup is cautiously positive but monitoring-oriented.

Primary-source earnings evidence is operationally constructive because of IBIO-600 clinical progress, pipeline expansion, and reported runway into fiscal 2028. However, the company is low coverage, pre-revenue, and highly event-driven. Consensus surprise, analyst revisions, options, short-interest, social coverage, and a trustworthy attribution of the post-release price reaction are unavailable; missing data is not positive evidence. Overall interpretation remains cautious and monitoring-oriented.

Recent company-specific coverage is sparse and concentrated around the July 1 FY2026 release and special dividend. The scheduled September 3 earnings trigger is not supported by a newer company release on the current IR page, so missing analyst reaction and price-reaction evidence should not be interpreted positively. The primary-source record is strong for FY2026 results but weak for near-term forward revisions.

Rocket Lab Next Neutron Milestone Is a Pad Delivery , Not a Launch . Id Hold Off on Buying the Stock .

Capital Formation Monitor: August 5, 2026

Stock market information for Vanguard Real Estate Index Fund ETF (VNQ)

1. As of Aug. 3; latest COT Jul. 28: SG CTA is +8.99% YTD and SG Trend +8.52%, but latest daily prints were −1.35% / −1.71%; trend breadth collapsed to 30% amid crude, USD and grain reversals.

Capital Formation Monitor: Week Ended July 29, 2026 What changed Capital is no longer merely funding AI compute capacity. It is increasingly assuming the construction, power-price, transmission, technology and credit risks required to make that capacity operational. The week’s...

Weekly Global Macro Liquidity, Credit and System-Stress Monitor

Weekly Global Macro Liquidity, Credit and System-Stress Monitor Market data through Friday, July 24, 2026. Fed balance-sheet data through July 22. Live geopolitical overlay through Sunday, July 26. Executive read Current regime: selective risk-off with a stagflationary bias, b...

Debt, leverage & balance-sheet health update: June 30, 2026

Global housing and real-asset cycle update, June 27, 2026